Table 3. Surgical findings for the patients received radical surgery after chemotherapy (N = 144).
| EOX (group A; N=63) No. of patients (%) | XELOX (group B; N=81) No. of patients (%) | P value | |
|---|---|---|---|
| Pathological response | |||
| Responders | 44/63 (69.8) | 47/81 (58.0) | 0.199 |
| pCR | 4/63 (6.3) | 8/81 (9.9) | 0.207 |
| Patients received D2 lymphadenectomy | 54/63 (85.7) | 70/81 (86.4) | 0.903 |
| Median total nodes | 30 (4-71) | 29 (2-66) | 0.754 |
| Median positive nodes | 3 (0-34) | 2 (0-31) | 0.421 |
| Median time from surgery to discharge | 9 (5-43) | 9 (6-72) | 0.752 |
| Pathological T stage | 0.260 | ||
| ypT0 | 6/63 (9.5) | 9/81 (11.1) | |
| ypT1 | 6/63 (9.5) | 7/81 (8.6) | |
| ypT2 | 11/63 (17.5) | 8/81 (9.9) | |
| ypT3 | 20/63 (31.7) | 22/81 (27.2) | |
| ypT4a | 18/63 (28.6) | 33/81 (40.7) | |
| ypT4b | 2/63 (3.2) | 2/81 (2.5) | |
| Pathological N stage | 0.905 | ||
| ypN0 | 22/63 (34.9) | 30/81 (37.1) | |
| ypN1 | 11/63 (17.5) | 12/81 (14.8) | |
| ypN2 | 10/63 (15.9) | 13/81 (16.0) | |
| ypN3a | 15/63 (23.8) | 17/81 (21.0) | |
| ypN3b | 5/63 (7.9) | 9/81 (11.1) | |
| Patients with T downstage | 42/63 (66.6) | 46/81 (56.8) | 0.301 |
| Patients with N downstage | 32/63 (50.1) | 42/81 (51.9) | 0.689 |